IP Library Granted Patent US 7,829,314
Granted Patent B2
US 7,829,314 · App. 12/476,912 · Granted Nov 9, 2010

Cleavage of nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,829,314
App. No.
12/476,912
Granted
Nov 9, 2010
Kind
B2
Abstract

The present invention relates to means for the detection and characterization of nucleic acid sequences, as well as variations in nucleic acid sequences. The present invention also relates to methods for forming a nucleic acid cleavage structure on a target sequence and cleaving the nucleic acid cleavage structure in a site-specific manner. The structure-specific nuclease activity of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof.

Claims (27)

1. A kit for detecting a target nucleic acid, comprising:

i) a purified thermostable FEN-1 endonuclease; and

ii) an oligonucleotide probe configured to hybridize to a target nucleic acid to form a FEN-1 endonuclease cleavage structure.

2. The kit of claim 1 , further comprising a nucleic acid molecule configured to hybridize to said target nucleic acid upstream of said oligonucleotide probe.

3. The kit of claim 2 , wherein said oligonucleotide probe comprises a label.

4. The kit of claim 2 , further comprising a stacker oligonucleotide configured to hybridize to said target nucleic acid adjacent to and downstream of said oligonucleotide probe.

5. The kit of claim 2 , wherein said purified FEN-1 endonuclease is from an archaebacterial species.

6. The kit of claim 5 , wherein said purified FEN-1 endonuclease is thermostable.

7. The kit of claim 2 , wherein said purified FEN-1 endonuclease is from an archaebacterial species selected from the group consisting of Pyrococcus furiosus and Methanococcus jannaschii.

8. The kit of claim 2 , further comprising a polymerase.

9. The kit of claim 7 , wherein said polymerase comprises a thermostable polymerase.

10. The kit of claim 8 , wherein said polymerase comprises a template-independent polymerase.

11. A kit for detecting a target sequence, comprising:

i) a purified thermostable FEN-1 endonuclease;

ii) a target nucleic acid, which comprises in 3′ to 5′ order a first region and a second region;

iii) a first oligonucleotide that is at least partially complementary to said first region of said target nucleic acid, and

iv) a second oligonucleotide comprising a 5′ portion and a 3′ portion, wherein said 3′ portion is complementary to said second region of said target nucleic acid and wherein said 5′ portion is not complementary to said target nucleic acid;

wherein said first and second oligonucleotides form an invasive cleavage structure when hybridized to said target nucleic acid.

12. The kit of claim 11 , wherein said 5′ portion of said second oligonucleotide comprises a label.

13. The kit of claim 11 , further comprising a stacker oligonucleotide configured to hybridize to said target nucleic acid adjacent to and downstream of said oligonucleotide probe.

14. The kit of claim 11 , wherein said purified FEN-1 endonuclease is from an archaebacterial species.

15. The kit of claim 14 , wherein said purified FEN-1 endonuclease is thermostable.

16. The kit of claim 14 , wherein said purified FEN-1 endonuclease is from an archaebacterial species selected from the group consisting of Pyrococcus furiosus and Methanococcus jannaschii.

17. The kit of claim 11 , further comprising a polymerase.

18. The kit of claim 17 , wherein said polymerase comprises a thermostable polymerase.

19. The kit of claim 17 , wherein said polymerase comprises a template-independent polymerase.

20. The kit of claim 17 , wherein said polymerase comprises a template-dependent polymerase.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
MERGER Recorded Oct 23, 2015
From: THIRD WAVE AGBIO, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: GEN-PROBE INCORPORATED
Reel/Frame 036934/0796 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
SEVENTH SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Jul 28, 2009
From: THIRD WAVE TECHNOLOGIES, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 023012/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2009
From: PRUDENT, JAMES R.; HALL, JEFF G.; LYAMICHEV, VICTOR I.; BROW, MARY ANN D.; DAHLBERG, JAMES E.
To: THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 022773/0196 →